Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of Artivion, Inc. (NYSE:AORT)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Artivion, Inc. (NYSE:AORT). In a filing disclosed on September 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in Artivion stock on July 16th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Mesabi Trust (NYSE:MSB) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of Praxis Precision Medicines (NASDAQ:PRAX) on 7/30/2026.
• Purchased $15,001 – $50,000 in shares of Alkermes (NASDAQ:ALKS) on 7/30/2026.
• Sold $15,001 – $50,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/30/2026.
• Sold $100,001 – $250,000 in shares of Alibaba Group (NYSE:BABA) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Adobe (NASDAQ:ADBE) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of SailPoint (NASDAQ:SAIL) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of Glacier Bancorp (NYSE:GBCI) on 7/21/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 7/21/2026.

Artivion Trading Up 0.1%

AORT stock opened at $25.59 on Tuesday. The company has a current ratio of 3.47, a quick ratio of 2.51 and a debt-to-equity ratio of 0.82. The firm has a market cap of $1.25 billion, a P/E ratio of -365.52 and a beta of 1.25. Artivion, Inc. has a 1-year low of $19.16 and a 1-year high of $48.25. The business’s 50 day moving average is $26.15 and its 200-day moving average is $29.08.

Artivion (NYSE:AORT) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.13 earnings per share for the quarter. Artivion had a positive return on equity of 6.07% and a negative net margin of 0.67%.The firm had revenue of $125.76 million for the quarter, compared to analysts’ expectations of $119.99 million. Equities analysts anticipate that Artivion, Inc. will post 0.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Artivion

Several hedge funds and other institutional investors have recently made changes to their positions in AORT. Caitong International Asset Management Co. Ltd acquired a new stake in Artivion in the third quarter worth about $27,000. Rockefeller Capital Management L.P. raised its stake in shares of Artivion by 150.0% during the fourth quarter. Rockefeller Capital Management L.P. now owns 665 shares of the company’s stock worth $30,000 after buying an additional 399 shares during the last quarter. Larson Financial Group LLC boosted its stake in Artivion by 148.5% in the fourth quarter. Larson Financial Group LLC now owns 942 shares of the company’s stock valued at $43,000 after acquiring an additional 563 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of Artivion by 47.7% during the 2nd quarter. Smartleaf Asset Management LLC now owns 1,667 shares of the company’s stock valued at $52,000 after acquiring an additional 538 shares during the last quarter. Finally, Kemnay Advisory Services Inc. acquired a new stake in shares of Artivion during the fourth quarter worth $79,000. 86.37% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Jean Holloway sold 977 shares of the firm’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $28.49, for a total transaction of $27,834.73. Following the sale, the senior vice president owned 184,118 shares of the company’s stock, valued at $5,245,521.82. This trade represents a 0.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO James Mackin sold 70,000 shares of the stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $28.95, for a total value of $2,026,500.00. Following the transaction, the chief executive officer owned 877,275 shares of the company’s stock, valued at approximately $25,397,111.25. The trade was a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 122,981 shares of company stock worth $3,181,531. Company insiders own 6.30% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on AORT. Needham & Company LLC reissued a “buy” rating and set a $44.00 price target on shares of Artivion in a report on Monday, July 20th. Canaccord Genuity Group raised their price objective on shares of Artivion from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Tuesday, August 18th. Stifel Nicolaus set a $45.00 target price on Artivion in a report on Monday, June 1st. Citigroup reaffirmed a “market outperform” rating on shares of Artivion in a report on Tuesday, July 21st. Finally, Weiss Ratings lowered Artivion from a “sell (d+)” rating to a “sell (d-)” rating in a research note on Tuesday, August 11th. Seven analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $44.83.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Artivion

Artivion, Inc (NYSE: AORT) is a global medical technology company that develops, manufactures and markets implantable tissue products and surgical devices for cardiac and vascular surgery. The company’s portfolio includes biologic implants derived from human and animal tissue, such as allografts and xenografts, as well as synthetic scaffolds and surgical adhesives. These products are designed to repair, reinforce or replace damaged cardiovascular and thoracic tissues during procedures such as aortic repair, heart valve surgery and vascular reconstruction.

Originally founded in 1984 under the name CryoLife, the company rebranded as Artivion in early 2022 to reflect its broader mission in cardiovascular innovation.